199 related articles for article (PubMed ID: 30297789)
1. Typing tumors using pathways selected by somatic evolution.
Wang S; Ma J; Zhang W; Shen JP; Huang J; Peng J; Ideker T
Nat Commun; 2018 Oct; 9(1):4159. PubMed ID: 30297789
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis of whole genome and transcriptome sequencing reveals diverse transcriptomic aberrations driven by somatic genomic changes in liver cancers.
Shiraishi Y; Fujimoto A; Furuta M; Tanaka H; Chiba K; Boroevich KA; Abe T; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Shibuya T; Nakano K; Sasaki A; Maejima K; Kitada R; Hayami S; Shigekawa Y; Marubashi S; Yamada T; Kubo M; Ishikawa O; Aikata H; Arihiro K; Ohdan H; Yamamoto M; Yamaue H; Chayama K; Tsunoda T; Miyano S; Nakagawa H
PLoS One; 2014; 9(12):e114263. PubMed ID: 25526364
[TBL] [Abstract][Full Text] [Related]
3. Mapping the protein-protein and genetic interactions of cancer to guide precision medicine.
Bouhaddou M; Eckhardt M; Chi Naing ZZ; Kim M; Ideker T; Krogan NJ
Curr Opin Genet Dev; 2019 Feb; 54():110-117. PubMed ID: 31288129
[TBL] [Abstract][Full Text] [Related]
4. SSA-ME Detection of cancer driver genes using mutual exclusivity by small subnetwork analysis.
Pulido-Tamayo S; Weytjens B; De Maeyer D; Marchal K
Sci Rep; 2016 Nov; 6():36257. PubMed ID: 27808240
[TBL] [Abstract][Full Text] [Related]
5. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
6. Systematic Analysis Reveals that Cancer Mutations Converge on Deregulated Metabolism of Arachidonate and Xenobiotics.
Gatto F; Schulze A; Nielsen J
Cell Rep; 2016 Jul; 16(3):878-95. PubMed ID: 27396332
[TBL] [Abstract][Full Text] [Related]
7. Classifying tumors by supervised network propagation.
Zhang W; Ma J; Ideker T
Bioinformatics; 2018 Jul; 34(13):i484-i493. PubMed ID: 29949979
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the genetic landscape of cancer--from genes to pathways.
Copeland NG; Jenkins NA
Trends Genet; 2009 Oct; 25(10):455-62. PubMed ID: 19818523
[TBL] [Abstract][Full Text] [Related]
9. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of genes, pathways, and TFs in nonsmoking Taiwan females with lung cancer.
Lv M; Wang L
Exp Lung Res; 2015 Mar; 41(2):74-83. PubMed ID: 25514196
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
12. The cancer cell map initiative: defining the hallmark networks of cancer.
Krogan NJ; Lippman S; Agard DA; Ashworth A; Ideker T
Mol Cell; 2015 May; 58(4):690-8. PubMed ID: 26000852
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Wilk G; Braun R
Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
[TBL] [Abstract][Full Text] [Related]
14. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors.
Goswami RS; Patel KP; Singh RR; Meric-Bernstam F; Kopetz ES; Subbiah V; Alvarez RH; Davies MA; Jabbar KJ; Roy-Chowdhuri S; Lazar AJ; Medeiros LJ; Broaddus RR; Luthra R; Routbort MJ
Clin Cancer Res; 2015 Jun; 21(11):2644-51. PubMed ID: 25695693
[TBL] [Abstract][Full Text] [Related]
15. Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.
Wang J; Zhang Y; Shen X; Zhu J; Zhang L; Zou J; Guo Z
Mol Biosyst; 2011 Apr; 7(4):1158-66. PubMed ID: 21279201
[TBL] [Abstract][Full Text] [Related]
16. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Link between the Germline and Somatic Genome in Cancer.
Geeleher P; Huang RS
Cancer Discov; 2017 Apr; 7(4):354-355. PubMed ID: 28373166
[TBL] [Abstract][Full Text] [Related]
18. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: Multilayered mutation analysis indicates divergent clonal evolution.
Thoma C
Nat Rev Urol; 2016 Apr; 13(4):179. PubMed ID: 26902334
[No Abstract] [Full Text] [Related]
20. Detection of driver pathways using mutated gene network in cancer.
Li F; Gao L; Ma X; Yang X
Mol Biosyst; 2016 Jun; 12(7):2135-41. PubMed ID: 27118146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
